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While halothane was without mutagenic activity in the Salmonella mutagenicity assay, even in the
presence of microsomal fractions, the urines of anesthesiologists induced mutations of the base-
substitution type.
On the basis oflaboratory as well as epidemiolog-
ical studies, anesthetic gases have been implicated
as responsible for an increased incidence of spon-
taneous abortions, congenital malformations, and
cancer among anesthesiologists (1-4). In view of
the established relationship between the ability to
induce genetic changes in bacteria and cancers in
mammals (5, 6), a number of investigators have at-
tempted to identify the anesthetic agent responsible
for the unwanted side-effects by determining their
ability to induce mutations in the Salmonella
mutagenicity assay developed by Ames and his as-
sociates (7). However, even though this system can
be adapted to the determination of the mutagenic
activity of gases (8), none of the commonly used
anesthetics was found to be mutagenic, even in the
presence of microsomal mixtures derived from rat
livers (8-10), although one ofthe anesthetic gases, a
vinyl chloride analog which is not commonly used,
was shown to possess genetic activity for
Salmonella typhimurium (11). It is known, how-
ever, that in man anesthetics are metabolized and
that some of these metabolites are recoverable in
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the urine (12). Thus in humans, halothane is bio-
transformed to trifluoroacetric acid, N-trifluoro-
acetyl-2-aminoethanol, N-acetyl-S-(2-bromo-2-
chloro-l,1-difluoroethyl)-L-cysteine as well as to
several other as yet unidentified urinary metabolites
(12). The presence in urines of the ethanolamide
and cysteine conjugates suggests the existence of
very reactive metabolic intermediates. Some of
these could, conceivably, still be present in the
urine. For these reasons we undertook an examina-
tion of the urines of persons exposed to anesthetic
gases. The immediate question which arose was a
decision whether to investigate the urines of surgi-
cal patients receiving a single-albeit heavy-dose of
these agents or to select a population of anes-
thesiologists who are exposed to these gases chron-
ically and who can be considered to be "saturated"
with three agents (13). In view of the report that
administration of halothane to anesthesiologists re-
sulted in a more rapid metabolism and in the forma-
tion of more metabolite when compared to controls
(14), it seemed that perhaps the liver ofthese physi-
cians are "induced" with respect to the enzymes
responsible for the biotransformation of halothane.
This result led us to investigate the mutagenic activ-
ity ofthe urines ofa group ofanesthesiologists. The
present is a very preliminary report ofour findings.
The data indicate that the urines ofthese persons do
contain material endowed with genetic activity.
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The Salmonella typhimurium mutagenicity pro-
cedure devised by Ames and his associates was fol-
lowed (7). Strains TA1535, TA1538, and TA100 (7)
were used in this study. The liver microsomes used
in this study were obtained from rats induced with
the polychlorinated biphenyl Arachlor 1254 (7).
The anesthesiologists who participated in this
study were on the staffoftwo ofour teaching hospi-
tals. Some of them had been anesthesiologists for
less than 1 year (residents) while others had several
years of continuous exposure to anesthetic gases.
All participants supplied histories which included
smoking habits, consumption of "ethnic" foods,
etc.
Urines were collected, sterile-filtered, and either
used immediately or stored at -20°C. Storage at
that temperature had no effect on mutagenic activ-
ity. Portions of unconcentrated urines were incor-
porated into the agar overlay.
Results
None of the urines tested exhibited mutagenic
activity for strain TA1538, the indicator strain for
frameshift mutations. On the other hand, all of the
urines derived from anesthesiologists exhibited
some mutagenic activity for strains TA1535 or
TA100. An analysis of the results indicates the pos-
sible presence in the urines ofmore than one type of
mutagenic substance (Table 1). Thus some of the
specimens exhibited activity only for strain TA100
(e.g., A2, A3, A8, A9, A12, A13). Of these, some
lost activity upon incubation in the presence of mi-
crosomes (e.g., A3, A13). Some of the specimens
induced mutations in strain TAlOO as well as
TA1535 (e.g., Al, A4, A5, A6, A7, A10). In each
irtstance the presence of rat liver microsomes
greatly diminished or eliminated altogether
mutagenicity for strain TA1535 (Table 1).
Samples obtained following 2 days of absence
from the operating room still possessed mutagenic
activity (i.e., A4 and A4a, AIO and AlOa, Table 1).
The mutagenic response of those urines with
considerable activity was dependent upon the
amount of urine added (Table 2, specimen A4).
There was no apparent correlation between smok-
ing habit and extent ofmutagenic response in these
nonconcentrated specimens.
Discussion
These results raise a number of interesting ques-
tions. Should the mutagenic activity present in the
urines of anesthesiologists indeed be due to active
Table 1. Mutagenic activity in the urines of anesthesiologists.a
Revertants per plateb
TA1535 TAIOO
Specimen -S9 +s9c - S9 +S9
A1 24 0 48 34
A2 4 0 15 48
A3 5 4 156 30
A4 127 10 143 119
A4a 64 3 146 28
A5 109 0 148 72
A6 90 20 108 29
A7 185 29 112 136
A8 3 11 47 145
A9 0 0 71 93
AIO 24 0 236 215
AlOa 60 0 59 44
All 23 5 121 109
A12 0 0 103 119
A13 5 0 60 0
A 14 42 0 54 60
A15 12 0 277 115
ao.2 ml ofsterile urine was incorporated into the agar overlay.
The values shown are the averages ofreplicate plates Represen-
tative colonies from each plate were selected and their histidine-
independent character confirmed.
bResults are expressed as revertants per plate above the inter-
nal controls. Thus for strain TA1535 and TAIOO, a background
of approx. 14 and 150 revertants per plate was subtracted from
each experimental value.
cS9 refers to the microsomal preparation derived from rat liv-
ers.
Table 2. Concentration dependence of mutagenic activity present
in the urines of an anesthesiologist.a
Revertants per plate
Amount added, TA1535 TAIOO
,ul per plate -S9 +S9b -S9 +S9
50 10 0 33 20
100 49 2 100 45
200 127 10 143 119
aResults are expressed as revertants per plate above control.
bS9 refers to the microsomal preparations derived from rat
livers.
metabolites of anesthetic gases, then it would be
expected that this activity was due to the reactive
intermediates that are formed presumably in the
liver. It would be expected thatonly a trace ofthese
will be excreted in the urines, the majority would
react with body fluid and cellular constituents. In-
deed it has been shown that only a small proportion
of these gases are recoverable in the urine, feces
and exhaled air (13, 15). The fact that microsomal
preparations reduced mutagenic activity is consis-
tent with the finding that these substances bind to
microsomes and are metabolized by such cell-free
preparations (16-18).
The finding that the urines from anesthesiologists
remained mutagenic even after 2 days of absence
from the operating room is compatible with the re-
Environmental Health Perspectives 222ports that anesthesiologists excrete anesthetics or
their metabolites for as long as 6 days following
their last day of exposure to these gases (14, 15).
The present findings require considerable eluci-
dation, they do, however, indicate the feasibility of
using the mutagenic index of urines for
epidemiological purposes and for the detection and
elucidation of the chemical nature of potential
mutagens and carcinogens present in body fluids.
Studies to identify the nature of the mutagenic
substance(s) are underway. We are very fortunate
in this respect that we are able to monitor our study
populations prior to their occupational exposure.
Thus because our medical students spend their first
two years on our Westchester County campus
without significant contact with the hospital, we are
able to follow them for periods prior to and during
their clinical years. Similarly, because the prospec-
tive anesthesiologists can be identified during their
senior year in medical school and/or during their
one-year of (medical) internship, we are able to
monitor their urines for one year prior to their
chronic exposure and subsequently. In this connec-
tion it is significant that extent of mutagenicity is
correlated with the number of years of exposure.
This may indicate an induction of specific enzymes
capable of metabolizing anesthetics. This is consis-
tent with the finding that anesthesiologists were
more efficient metabolizers of halothane (14).
REFERENCES
1. Corbett, T. H. Cancer and congenital anomalies associated
with anesthetics. Ann. N. Y. Acad. Sci. 271: 58 (1976).
2. Pharoah, P. 0. D., Alberman, E., and Doyle, P. Outcome
ofpregnancy among women in anesthetic practice. Lancet 1:
34 (1977).
3. Cohen, E. N. Anesthetics and cancer. Anesthesiology 44:
459 (1976).
4. Anonymous. Chronic exposure to anesthetic gases is a
danger to medical workers. Chem. Eng. News, 55: 7 (March
7, 1977).
5. McCann, J., et al. Detection ofcarcinogens as mutagens in
the Salmonella/microsome test: assay of 300 chemicals.
Proc. Nat. Acad. Sci. U. S. 72: 5135 (1975).
6. McCann, J., and Ames, B. N. Detection ofcarcinogens as
mutagens in the Salmonella/microsome test: assay of 300
chemicals. Discussion. Proc. Nat. Acad. Sci. U. S. 73: 950
(1976).
7. Ames, B. N., McCann, J., and Yamasaki, E. Methods for
the detection of carcinogens and mutagens with the
Salmonella/mammalian-microsome mutagenicity test. Mut.
Res. 31: 347 (1975).
8. Baden, J. M., et al. Mutagenicity of volatile anesthetics:
halothane. Anesthesiology 45: 311 (1976).
9. Uehleke, H., et al. Covalent binding of haloalkanes to liver
constituents, but absence of mutagenicity on bacteria in a
metabolizing test system. Mut. Res. 38: 114 (1976).
10. McCoy, E. C., et al. Presence of mutagenic substances in
the urines of anesthesiologists. Mut. Res., in press.
11. Baden, J. M., et al. Mutagenicity offluroxene. Anesthesiol-
ogy 46: 346 (1976).
12. Cohen, E. N., et al. Urinary metabolites of halothane in
man. Anesthesiology 43: 392 (1975).
13. Mazze, R. I., and Hitt, B. A. Methoxyflurane metabolism.
Anesthesiology 44: 369 (1976).
14. Cascorbi, H. F., Blake, D. A., and Helrich, M. Differences
in the biotransformation of halothane in man. Anesthesiol-
ogy 32: 119 (1970).
15. Yoshimura, N., Holaday, D. A., and Fiserova-Bergerova,
V. Metabolism of methoxyflurane in man. Anesthesiology
44: 372 (1976).
16. Berman, M. C., Ivanetich, K. M., and Kench, J. E. The
effects ofhalothane on hepatic microsomal electron transfer.
Biochem. J. 148: 179 (1975).
17. Adler, L., Brown, B. R.,Jr., and Thompson, M. F. Kinetics
of methoxyflurane biotransformation with reference to sub-
strate inhibition. Anesthesiology 44: 380 (1976).
18. Reynolds, E. S., and Moslen, M. T. Metabolism of(4C-1)-
halothane in vivo-effects of multiple halothane anesthesia,
phenobarbital and carbon tetrachloride pretreatment.
Biochem. Pharmacol. 24: 2075 (1975).
December 1977 223